Darbepoetin alfas farmakokinetik er blevet klinisk undersøgt hos patienter med kronisk nyresvigt efter intravenøs og subkutan administration.
The pharmacokinetics of darbepoetin alfa has been studied clinically in chronic renal failure patients following intravenous and subcutaneous administration.